While the antigen levels were observed to be lower in the ensitrelvir group compared to those of the other groups, the differences did not reach statistical significance when compared to the molnupiravir (p=0.1275) and remdesivir groups (p=0.0662) (Figure 2b ).
← all excerpts
Real-World Efficacy of Ensitrelvir in Hospitalized Patients With COVID-19 in Japan: A Retrospective Observational Study.
1
0.1275
0.1275